Julia Zhu, MD, PhD
Dr. Julia Zhu serves as VP, Head of Drug Safety and Pharmacovigilance at Overland Pharmaceuticals.
Prior to Overland, Dr. Zhu served as the Head of Drug Safety and Pharmacovigilance at dMed, built up and led an integrated PV function which was growing to a well-recognized PV service provider in China. Prior to dMed, Dr. Zhu was Safety Medical Director of Oncology at Pfizer, responsible for safety management of key Oncology products including crizotinib and sunitinib. She also worked at Sunway Biotech as Clinical Research Scientist for oncolytic virus products. Before joining industry, Dr. Zhu was a licensed physician in internal medicine. Overall, Dr. Zhu brings 9-year experience of clinical practice and 15-year experience in Oncology drug development with a focus on drug safety and pharmacovigilance.
Dr. Zhu received her MD from Shanghai Medical University and PhD degree in Clinical Medicine from Shanghai Medical College, Fudan University.